Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in J Pediatr Retrieve available abstracts of 41 articles: HTML format

Single Articles

December 2022
1. ROSS LF
   50 Years Ago in TheJournalofPediatrics: Points to Consider: Sickle Cell Screening.
   J Pediatr. 2022;251:126.
   PubMed    
   
   
   November 2022
2. SAMBHU HEMA L, Gunasekaran PK, Tandon M, Didel S, et al
   Retinopathy of Megaloblastic Anemia: Treatable and Reversible.
   J Pediatr. 2022;250:106-107.
   PubMed    
   
   
   October 2022
3. SHERWIN NK, Ott MA
   50 Years Ago in TheJournalofPediatrics: Anemia as a Marker of Social Determinants of Health: Then and Now.
   J Pediatr. 2022;249:110.
   PubMed    
   
   
   June 2022
4. BAHR TM, Lawrence SM, Henry E, Ohls RK, et al
   Severe anemia at birth - incidence and implications.
   J Pediatr. 2022 Jun 1. pii: S0022-3476(22)00516.
   PubMed     Abstract available
   
   
   
5. SOLEVAG AL, Andresen JH, Saugstad OD
   50 Years Ago in TheJournalofPediatrics: Iron Supplementation in Infants Born at Term.
   J Pediatr. 2022;245:110.
   PubMed    
   
   
   
6. MANTADAKIS E
   Serum Ferritin Threshold for Iron Deficiency Screening in One-Year-Old Children.
   J Pediatr. 2022;245:12-14.
   PubMed    
   
   
   
7. MUKHTAROVA N, Ha B, Diamond CA, Plumb AJ, et al
   Serum Ferritin Threshold for Iron Deficiency Screening in One-Year-Old Children.
   J Pediatr. 2022;245:217-221.
   PubMed     Abstract available
   
   
   May 2022
8. IIO K, Ishida Y
   Blue sclera in an infant with severe iron deficiency anemia.
   J Pediatr. 2022 May 19. pii: S0022-3476(22)00480.
   PubMed    
   
   
   
9. LANDRY C, Dorling J, Kulkarni K, Campbell-Yeo M, et al
   Post discharge iron status in very preterm infants receiving prophylactic iron supplementation after birth.
   J Pediatr. 2022 May 13. pii: S0022-3476(22)00424.
   PubMed     Abstract available
   
   
   April 2022
10. STRUMPH K, Manwani D
    50 Years Ago in TheJournalofPediatrics: Newborn Screening for Sickle Cell Disease: A Promise (Un)Fulfilled.
    J Pediatr. 2022;243:68.
    PubMed    
    
    
    
11. AZOULAY D, Levov I, Shaoul E, Kuperman AA, et al
    Laboratory Indices in Patients with Positive and Borderline Flow Cytometry Eosin-5-Maleimide-Screening Test Results for Hereditary Spherocytosis.
    J Pediatr. 2022;243:142-145.
    PubMed     Abstract available
    
    
    
12. GONCALVES JS, Tribovane D, Pires M, Lopes RS, et al
    Cranial Masses in Sickle Cell Disease.
    J Pediatr. 2022;243:228-230.
    PubMed    
    
    
    February 2022
13. RAMIREZ-LARA M, Gonzalez-Moctezuma K
    50 Years Ago in TheJournalofPediatrics: 50 Years into Understanding Hemolytic-Uremic Syndrome.
    J Pediatr. 2022;241:132.
    PubMed    
    
    
    November 2021
14. GRAF CM, Nichele S, Siviero RB, Loth G, et al
    Ocular Manifestations in Patients With Fanconi Anemia: A Single Center Experience Including 106 Patients.
    J Pediatr. 2021 Nov 10. pii: S0022-3476(21)01078.
    PubMed     Abstract available
    
    
    
15. ARDISSINO G, Daprai L, Liporace MF, Piccoli M, et al
    Reply.
    J Pediatr. 2021;238:345.
    PubMed    
    
    
    
16. COSTIGAN C, Wildes DM, Riordan M, Awan A, et al
    Why exclude children with Shiga toxin genotype 1 alone from hemolytic uremic syndrome screening?
    J Pediatr. 2021;238:344-345.
    PubMed    
    
    
    October 2021
17. ARDISSINO G, Vignati C, Masia C, Capone V, et al
    Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    J Pediatr. 2021;237:34-40.
    PubMed     Abstract available
    
    
    September 2021
18. WAN Y, Gong X, Cheng S, Yin Z, et al
    Short Stature in Patients with Diamond-Blackfan Anemia: A Cross-Sectional Study.
    J Pediatr. 2021 Sep 17. pii: S0022-3476(21)00889.
    PubMed     Abstract available
    
    
    
19. KNIJNENBURG PJC, Spruijt MS, Jansen L, Rijken M, et al
    Neurodevelopmental Trajectories of Preterm Born Twin-Twin Transfusion Syndrome Survivors: From Birth to 5 Years of Age.
    J Pediatr. 2021 Sep 7. pii: S0022-3476(21)00874.
    PubMed     Abstract available
    
    
    August 2021
20. MAYOCK DE, Gogcu S, Puia-Dumitrescu M, Shaw DWW, et al
    Association between Term Equivalent Brain MRI and 2 Year Outcomes in Extremely Preterm Infants: A Report from the PENUT Trial Cohort.
    J Pediatr. 2021 Aug 26. pii: S0022-3476(21)00825.
    PubMed     Abstract available
    
    
    
21. BAHR TM, Christensen TR, Henry E, Wilkes J, et al
    Neonatal Reference Intervals for the CBC Parameters "Micro-R" and "HYPO-He": Sensitivity Beyond the Red Cell Indices for Identifying Microcytic and Hypochromic Disorders.
    J Pediatr. 2021 Aug 10. pii: S0022-3476(21)00757.
    PubMed     Abstract available
    
    
    
22. GUIVARCH C, Sacri AS, Levy C, Bocquet A, et al
    Clinical Prediction of Iron Deficiency at Age 2 Years: A National Cross-sectional Study in France.
    J Pediatr. 2021;235:212-219.
    PubMed     Abstract available
    
    
    
23. SANDERS E, Brown CC, Blaszak RT, Crawford B, et al
    Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.
    J Pediatr. 2021;235:144-148.
    PubMed     Abstract available
    
    
    July 2021
24. GERMAN KR, Vu PT, Comstock BA, Ohls RK, et al
    Enteral Iron Supplementation in Extremely Preterm Infants and its Positive Correlation with Neurodevelopment; Post Hoc Analysis of the PENUT Randomized Controlled Trial.
    J Pediatr. 2021 Jul 26. pii: S0022-3476(21)00686.
    PubMed     Abstract available
    
    
    
25. LEE SOLEVAG A, Andresen JH, Saugstad OD
    50 Years Ago in TheJournalofPediatrics: Neonatal Anemia Prevention and Treatment.
    J Pediatr. 2021;234:211.
    PubMed    
    
    
    
26. GIAMPIETRO PF
    50 Years Ago in THEJournal ofPediatrics: Endocrine Abnormalities in Fanconi Anemia.
    J Pediatr. 2021;234:194.
    PubMed    
    
    
    May 2021
27. HAU DK, Ambrose EE, Smart LR, Kayange NM, et al
    Linkage to Care Intervention to Improve Post-Hospital Outcomes Among Children with Sickle Cell Disease in Tanzania: A Pilot Study.
    J Pediatr. 2021;232:290-293.
    PubMed     Abstract available
    
    
    
28. LIN CY, Xie J, Freedman SB, McKee RS, et al
    Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments.
    J Pediatr. 2021;232:200-206.
    PubMed     Abstract available
    
    
    March 2021
29. SALINAS SILVA CA, Ortega Alonzo SE
    50 Years Ago in TheJournalofPediatrics: Therapy of Hemolytic Uremic Syndrome, a 50-Year Update.
    J Pediatr. 2021;230:160.
    PubMed    
    
    
    
30. KARKOSKA KA, Haber K, Elam M, Strong S, et al
    Academic Challenges and School Service Utilization in Children with Sickle Cell Disease.
    J Pediatr. 2021;230:182-190.
    PubMed     Abstract available
    
    
    February 2021
31. PARKIN PC, Borkhoff CM, Macarthur C, Abdullah K, et al
    Randomized Trial of Oral Iron and Diet Advice versus Diet Advice Alone in Young Children with Non-Anemic Iron Deficiency.
    J Pediatr. 2021 Feb 3. pii: S0022-3476(21)00107.
    PubMed     Abstract available
    
    
    January 2021
32. ASKENAZI DJ, Heagerty PJ, Schmicker RH, Brophy P, et al
    The Impact of Erythropoietin on Short and Long-term Kidney-Related Outcomes in Extremely Low Gestational Age Neonates. Results of a Multi-center Double-Blind Placebo-Controlled Randomized Clinical Trial.
    J Pediatr. 2021 Jan 20. pii: S0022-3476(21)00065.
    PubMed     Abstract available
    
    
    December 2020
33. STRUMPH K, Morrone K
    50 Years Ago in TheJournalofPediatrics: The Changing Landscape of Iron Deficiency Diagnosis.
    J Pediatr. 2020;227:113.
    PubMed    
    
    
    October 2020
34. YANG W, Liu B, Gao R, Snetselaar LG, et al
    Association of Anemia with Neurodevelopmental Disorders in A Nationally Representative Sample of US Children.
    J Pediatr. 2020 Oct 6. pii: S0022-3476(20)31172.
    PubMed     Abstract available
    
    
    September 2020
35. FARRELL MH, Sims AM, La Pean Kirschner A, Farrell PM, et al
    Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell.
    J Pediatr. 2020;224:44-50.
    PubMed     Abstract available
    
    
    August 2020
36. ATTIA M, Kripalani S, Darbari I, Nickel RS, et al
    Parents of Children with Sickle Cell Disease Are Interested in Preimplantation Genetic Testing.
    J Pediatr. 2020;223:178-182.
    PubMed     Abstract available
    
    
    July 2020
37. GUO R, Neumann D, Lafferty M, Boelig R, et al
    Prevalence and Utility of Low Mean Corpuscular Volume in Infants Admitted to the Neonatal Intensive Care Unit.
    J Pediatr. 2020 Jul 20. pii: S0022-3476(20)30955.
    PubMed     Abstract available
    
    
    
38. ARISAKA O, Ichikawa G, Imataka G, Koyama S, et al
    Iron, ketone bodies, and brain development.
    J Pediatr. 2020;222:262-263.
    PubMed    
    
    
    
39. WARE RE, Marahatta A, Ware JL, McElhinney K, et al
    Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS).
    J Pediatr. 2020;222:236-239.
    PubMed     Abstract available
    
    
    June 2020
40. ZHOU R, Joshi P, Katsushima K, Liang W, et al
    The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases.
    J Pediatr. 2020;221S:S11-S19.
    PubMed    
    
    
    May 2020
41. FARRELL MH, La Pean Kirschner A, Tluczek A, Farrell PM, et al
    Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status.
    J Pediatr. 2020 May 6. pii: S0022-3476(20)30356.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: